Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| CHR#H9377-29543-02 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Cliff Lede Foundation | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
We tested the following hypotheses:
Study Interventions: There will be a 12-week intervention period.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| A | Experimental | Restorative yoga therapy group: one orientation workshop for 3 hours, then twice-weekly group yoga therapy classes for first 5 weeks followed by once-weekly group yoga classes for another 5 weeks. The group will also be asked to practice their yoga postures at home for 30 minutes three times per week. |
|
| B | No Intervention | The control group is a wait-list control group with no active intervention. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Restorative yoga therapy | Behavioral | 3-hour workshop at study initiation. Then twice-weekly group yoga classes for 5 weeks, then once-weekly group yoga classes for 5 weeks. Home yoga practice for 90 minutes/week throughout the 10 week trial. |
| Measure | Description | Time Frame |
|---|---|---|
| Fasting plasma glucose level | 10 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Feasability of yoga postures | 10 weeks | |
| Adherence to protocol | 10 weeks | |
| Blood pressure |
Not provided
Inclusion Criteria:
to be between the ages of 30 and 65 years,
fulfill at least three criteria for the metabolic syndrome per the NCEP guidelines:
report an underactive or sedentary lifestyle defined as accumulating less than 30 minutes of moderate intensity endurance exercise 5 days per week.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Alka M. Kanaya, MD | University of California, San Francisco | Principal Investigator |
| Deborah Grady, MD, MPH | University of California, San Francisco | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of California, San Francisco | San Francisco | California | 94115 | United States |
Not provided
| ID | Term |
|---|---|
| D024821 | Metabolic Syndrome |
| D050177 | Overweight |
| D057185 | Sedentary Behavior |
| ID | Term |
|---|---|
| D007333 | Insulin Resistance |
| D006946 | Hyperinsulinism |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 10 weeks |
| Insulin sensitivity | 10 weeks |
| Weight | 10 weeks |
| Waist circumference | 10 weeks |
| Heart rate variability | 10 weeks |
| D009750 |
| Nutritional and Metabolic Diseases |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D001835 | Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D001519 | Behavior |